GLP-1 Drugs Have Changed Obesity Treatment, But Many Stop Taking Them Newer weight loss medications, including glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Ozempic, Wegovy, and Rybelsus) and tirzepatide (Mounjaro and Zepbound), have significantly reshaped obesity treatment by helping many patients lose substantial amounts of weight
Ruggiero et al
GLP-1s are a class of medications, often injectables, first introduced in 2005 to treat diabetes
JAMA Surgery study of 1,046 patients identified independent risk factors for food retention with GLP-1 RA use (odds ratio 9.19, 95% confidence interval 2.7330.8), with tirzepatide demonstrating the strongest association amongst available agents [33]
A well-rounded plan is what will really move the needle on your numbers
The goal is to stop pretending that every product sold in a pretty bottle is automatically harmless